OR WAIT null SECS
July 29, 2014
Redbiotec and GE Healthcare Life Sciences develop a novel manufacturing process for virus-like particles.
The regulatory filing marks the first step in the approval process toward making RTS,S available as an addition to existing tools currently recommended for malaria prevention.
June 16, 2014
Novartis facility becomes the first US site licensed by the FDA to produce cell-culture influenza vaccines.
May 27, 2014
GSK reports 5-year vaccine price freeze for countries graduating from GAVI Alliance.
May 02, 2014
New formulations and expanded vaccine production are encouraged.
April 10, 2014
FDA develops an assay that could speed the release of pandemic influenza vaccines.
March 26, 2014
Pfizer intends to submit a biologics license application for its investigational Meningococcal B vaccine candidate, Bivalent rlp2086, to FDA by mid-2014.
March 11, 2014
HHS plan makes progress in ensuring availability of safe vaccines.
February 11, 2014
EMA releases an update on its flu vaccine guidance.
January 06, 2014
A study led by Stanford University explains why men may have weaker responses to vaccines than women.